Skip to main content
DOUBLE MEDICAL TECHNOLOGY INC. logo

DOUBLE MEDICAL TECHNOLOGY INC. — Investor Relations & Filings

Ticker · 002901 ISIN · CNE1000032W7 LEI · 836800DECKX5CGFNMD42 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 963 across all filing types
Latest filing 2022-03-29 Notice of Dividend Amou…
Country CN China
Listing Shenzhen Stock Exchange 002901

About DOUBLE MEDICAL TECHNOLOGY INC.

https://www.double-medical.com

Double Medical Technology Inc. specializes in the development, manufacturing, and distribution of medical devices, with a primary focus on orthopedic solutions. The company's extensive product portfolio includes trauma fixation systems, spinal implants, joint prosthesis, and neurosurgical devices. Additionally, it provides specialized surgical instruments and advanced wound care products. Double Medical emphasizes research and innovation to deliver clinically effective solutions for complex musculoskeletal conditions. Its manufacturing processes adhere to international quality standards, ensuring the reliability of its implants and instruments used in hospitals and surgical centers worldwide. The company serves a global market, providing comprehensive support for orthopedic surgeons through its diverse range of reconstructive and regenerative medical technologies.

Recent filings

Filing Released Lang Actions
2021年度利润分配预案的公告
Notice of Dividend Amount Classification · 95% confidence The document is a public announcement from a company regarding its 2021 annual profit distribution plan. It includes details about the profit distribution proposal, board and independent directors' opinions, and supervisory board opinions. The document states that the profit distribution plan will be submitted to the shareholders' meeting for approval. It does not contain the full annual report or detailed financial statements but rather focuses on the dividend distribution plan and related approvals. The document length is short (1488 characters) and is an announcement of a profit distribution plan, which aligns with a Notice of Dividend Amount filing rather than a full Annual Report or Earnings Release. Therefore, the appropriate classification is Notice of Dividend Amount (DIV).
2022-03-29 Chinese
2022-016 关于2022年度继续使用暂时闲置的自有资金进行现金管理的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by a company regarding the continued use of temporarily idle funds for cash management through purchasing financial products. It includes details about the purpose, amount, investment types, risk control measures, and approvals by the board, independent directors, and supervisory board. There are no financial statements or detailed financial data presented. The document is a formal announcement of a corporate financing or capital management activity rather than a full financial report or earnings release. It fits best under the category of Capital/Financing Update (CAP). The document length is under 5,000 characters, but it contains substantive information about the financing activity, not just a report publication announcement or a regulatory filing. Therefore, the classification is CAP with high confidence.
2022-03-29 Chinese
2021年度独立董事述职报告（王艳艳）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Report for the year 2021" from a company named 大博医疗科技股份有限公司. It details the independent director's activities, opinions on various board meetings, assessments of company governance, internal controls, use of raised funds, audit firm reappointment, stock incentive plans, and other governance-related matters for the fiscal year 2021. The content is focused on the independent director's duties, opinions, and oversight rather than presenting full financial statements or comprehensive annual financial performance. It is a detailed report on board/management oversight and governance activities rather than a full annual report or audit report. Therefore, the document fits best under the category of Board/Management Information (MANG), as it reports on board activities, independent director opinions, and governance oversight for the year.
2022-03-29 Chinese
年度关联方资金占用专项审计报告
Audit Report / Information Classification · 95% confidence The document is an audit report specifically focused on the special audit of non-operating fund occupation and other related party fund transactions for the year 2021. It includes an auditor's opinion, references to auditing standards, and detailed financial tables related to these transactions. The document is not a full annual report but a standalone audit report on a specific financial matter, which fits the definition of an Audit Report / Information (AR). The length and content confirm it is the report itself, not just an announcement or certification. FY 2021
2022-03-29 Chinese
中信证券股份有限公司关于大博医疗科技股份有限公司2022年度继续使用暂时闲置的自有资金进行现金管理的核查意见
Audit Report / Information Classification · 95% confidence The document is a formal opinion from a sponsoring institution (中信证券股份有限公司) regarding the use of temporarily idle funds by 大博医疗科技股份有限公司 for cash management in 2022. It includes detailed descriptions of the purpose, scope, risk control measures, and approvals by the board, independent directors, and supervisory board. The document references regulatory rules and confirms compliance with relevant listing rules and company articles. It is not a financial report like an annual or interim report, nor is it a simple announcement or certification. Instead, it is a detailed audit or verification opinion on a specific financial management activity, which fits the definition of an Audit Report / Information (AR). The document length is under 5,000 characters but contains substantive content and formal opinions, not just a brief announcement or certification, so it is not RPA or RNS. FY 2022
2022-03-29 Chinese
内部控制规则落实自查表
Regulatory Filings Classification · 95% confidence The document is an internal control self-assessment checklist for a company, detailing the implementation of internal control rules across various areas such as internal audit, information disclosure, insider trading controls, fundraising, related party transactions, guarantees, and major investments. It does not contain financial statements, earnings data, or detailed management discussion of financial results. It is not a report of audit results but rather a compliance and internal control status document. The document length is 3450 characters, which is relatively short and focused on internal control procedures rather than financial reporting or announcements. Therefore, it does not fit categories like Annual Report (10-K), Interim Report (IR), Audit Report (AR), or Earnings Release (ER). It is also not a regulatory announcement or a report publication announcement. The content aligns best with internal control and governance practices, but since it is a checklist and self-assessment related to internal controls and compliance, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory compliance documents that do not fit other specific categories.
2022-03-29 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.